Voices
Jeff Yang
Jeff Yang/yang-lab.mgh.harvard.edu

Jeff Yang: Segmentectomy vs Lobectomy for Patients With 2- to 3-cm Non-Small Cell Lung Cancer

Jeff Yang, Thoracic surgeon at Mass General Surgery, shared a post about recent article he and his colleagues authored on X:

“Our team, led by Camille Mathey-Andrews, Alex Potter and Deepti Srinivasan, published a study of segmentectomy vs lobectomy for patients with 2-3 cm non-small-cell lung cancer in Chest.

We found similar long-term survival between the two groups. In the post CALGB140503 / JCOG0802 era, is it time to consider a randomized trial in the U.S. comparing lobectomy vs sublobar resection for larger Stage I tumors?”

Title: Segmentectomy vs Lobectomy for Patients With 2- to 3-cm Non-Small Cell Lung Cancer

Authors: Camille A. Mathey-Andrews, Alexandra L. Potter, Deepti Srinivasan, Priyanka Senthil, Hiba Elkhatib, Danny Wang, Arvind Kumar, Michael Lanuti, Lana Schumacher, Chi-Fu Jeffrey Yang

Read Full Article.

Jeff Yang

More posts featuring Jeff Yang on OncoDaily.

Alexandra L. Potter Arvind Kumar Camille A. Mathey-Andrews cancer Chi-Fu Jeffrey Yang Danny Wang Deepti Srinivasan Hiba Elkhatib Jeff Yang Lana Schumacher Michael Lanuti OncoDaily Oncology Priyanka Senthil